List of Tables
Table 1. Prostate Cancer Vaccines Market Trends
Table 2. Prostate Cancer Vaccines Market Drivers & Opportunity
Table 3. Prostate Cancer Vaccines Market Challenges
Table 4. Prostate Cancer Vaccines Market Restraints
Table 5. Global Prostate Cancer Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prostate Cancer Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Global Prostate Cancer Vaccines Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Prostate Cancer Vaccines Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Prostate Cancer Vaccines Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Prostate Cancer Vaccines Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Prostate Cancer Vaccines Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Prostate Cancer Vaccines
Table 13. Global Prostate Cancer Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Vaccines as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Prostate Cancer Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Prostate Cancer Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Prostate Cancer Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Prostate Cancer Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Prostate Cancer Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Prostate Cancer Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Prostate Cancer Vaccines Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Prostate Cancer Vaccines Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Prostate Cancer Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Prostate Cancer Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Prostate Cancer Vaccines Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Prostate Cancer Vaccines Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Prostate Cancer Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Prostate Cancer Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Prostate Cancer Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Prostate Cancer Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Prostate Cancer Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Prostate Cancer Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Prostate Cancer Vaccines Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Prostate Cancer Vaccines Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Prostate Cancer Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Prostate Cancer Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Prostate Cancer Vaccines Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Prostate Cancer Vaccines Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Prostate Cancer Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Prostate Cancer Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Prostate Cancer Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Prostate Cancer Vaccines Sales Value by Region (2019-2024) & (%)
Table 44. Global Prostate Cancer Vaccines Sales Value by Region (2025-2030) & (%)
Table 45. Global Prostate Cancer Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Prostate Cancer Vaccines Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Prostate Cancer Vaccines Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Prostate Cancer Vaccines Sales Volume by Region (2019-2024) & (%)
Table 49. Global Prostate Cancer Vaccines Sales Volume by Region (2025-2030) & (%)
Table 50. Global Prostate Cancer Vaccines Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Prostate Cancer Vaccines Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Prostate Cancer Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Prostate Cancer Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Prostate Cancer Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Prostate Cancer Vaccines Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Prostate Cancer Vaccines Sales Volume, (2025-2030) & (K Units)
Table 57. Dendreon Corporation Company Information
Table 58. Dendreon Corporation Introduction and Business Overview
Table 59. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Dendreon Corporation Prostate Cancer Vaccines Product Offerings
Table 61. Dendreon Corporation Recent Development
Table 62. Bavarian Nordic Company Information
Table 63. Bavarian Nordic Introduction and Business Overview
Table 64. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Bavarian Nordic Prostate Cancer Vaccines Product Offerings
Table 66. Bavarian Nordic Recent Development
Table 67. Advantagene Company Information
Table 68. Advantagene Introduction and Business Overview
Table 69. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Advantagene Prostate Cancer Vaccines Product Offerings
Table 71. Advantagene Recent Development
Table 72. OncBioMune Pharmaceuticals Company Information
Table 73. OncBioMune Pharmaceuticals Introduction and Business Overview
Table 74. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Offerings
Table 76. OncBioMune Pharmaceuticals Recent Development
Table 77. Advaxis immunotherapies Company Information
Table 78. Advaxis immunotherapies Introduction and Business Overview
Table 79. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Advaxis immunotherapies Prostate Cancer Vaccines Product Offerings
Table 81. Advaxis immunotherapies Recent Development
Table 82. SOTIO Company Information
Table 83. SOTIO Introduction and Business Overview
Table 84. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. SOTIO Prostate Cancer Vaccines Product Offerings
Table 86. SOTIO Recent Development
Table 87. Cleveland BioLabs Inc. Company Information
Table 88. Cleveland BioLabs Inc. Introduction and Business Overview
Table 89. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Offerings
Table 91. Cleveland BioLabs Inc. Recent Development
Table 92. Curevac AG Company Information
Table 93. Curevac AG Introduction and Business Overview
Table 94. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Curevac AG Prostate Cancer Vaccines Product Offerings
Table 96. Curevac AG Recent Development
Table 97. Mediolanum Farmaceutici Company Information
Table 98. Mediolanum Farmaceutici Introduction and Business Overview
Table 99. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Mediolanum Farmaceutici Prostate Cancer Vaccines Product Offerings
Table 101. Mediolanum Farmaceutici Recent Development
Table 102. Pfizer Inc. Company Information
Table 103. Pfizer Inc. Introduction and Business Overview
Table 104. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Pfizer Inc. Prostate Cancer Vaccines Product Offerings
Table 106. Pfizer Inc. Recent Development
Table 107. Vaccitech Company Information
Table 108. Vaccitech Introduction and Business Overview
Table 109. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Vaccitech Prostate Cancer Vaccines Product Offerings
Table 111. Vaccitech Recent Development
Table 112. Sensei Biotherapeutics Company Information
Table 113. Sensei Biotherapeutics Introduction and Business Overview
Table 114. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Sensei Biotherapeutics Prostate Cancer Vaccines Product Offerings
Table 116. Sensei Biotherapeutics Recent Development
Table 117. Medigene AG Company Information
Table 118. Medigene AG Introduction and Business Overview
Table 119. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Medigene AG Prostate Cancer Vaccines Product Offerings
Table 121. Medigene AG Recent Development
Table 122. Ultimovacs Company Information
Table 123. Ultimovacs Introduction and Business Overview
Table 124. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Ultimovacs Prostate Cancer Vaccines Product Offerings
Table 126. Ultimovacs Recent Development
Table 127. Oncovir Inc. Company Information
Table 128. Oncovir Inc. Introduction and Business Overview
Table 129. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Oncovir Inc. Prostate Cancer Vaccines Product Offerings
Table 131. Oncovir Inc. Recent Development
Table 132. UbiVac Company Information
Table 133. UbiVac Introduction and Business Overview
Table 134. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. UbiVac Prostate Cancer Vaccines Product Offerings
Table 136. UbiVac Recent Development
Table 137. Momotaro-Gene Inc. Company Information
Table 138. Momotaro-Gene Inc. Introduction and Business Overview
Table 139. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Momotaro-Gene Inc. Prostate Cancer Vaccines Product Offerings
Table 141. Momotaro-Gene Inc. Recent Development
Table 142. Vaccibody AS Company Information
Table 143. Vaccibody AS Introduction and Business Overview
Table 144. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Vaccibody AS Prostate Cancer Vaccines Product Offerings
Table 146. Vaccibody AS Recent Development
Table 147. AlphaVax Inc. Company Information
Table 148. AlphaVax Inc. Introduction and Business Overview
Table 149. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. AlphaVax Inc. Prostate Cancer Vaccines Product Offerings
Table 151. AlphaVax Inc. Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Prostate Cancer Vaccines Downstream Customers
Table 155. Prostate Cancer Vaccines Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Vaccines Product Picture
Figure 2. Global Prostate Cancer Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prostate Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Prostate Cancer Vaccines Sales Volume (2019-2030) & (K Units)
Figure 5. Global Prostate Cancer Vaccines Sales Price (2019-2030) & (US$/Unit)
Figure 6. Prostate Cancer Vaccines Report Years Considered
Figure 7. Global Prostate Cancer Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Prostate Cancer Vaccines Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Vaccines Revenue in 2023
Figure 10. Prostate Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Tablet Picture
Figure 12. Injection Picture
Figure 13. Global Prostate Cancer Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Prostate Cancer Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Prostate Cancer Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Prostate Cancer Vaccines Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Prostate Cancer Vaccines Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Prostate Cancer Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Prostate Cancer Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Prostate Cancer Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Prostate Cancer Vaccines Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Prostate Cancer Vaccines Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Prostate Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Prostate Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Prostate Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Prostate Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Prostate Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Prostate Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Prostate Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Prostate Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Prostate Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Prostate Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Prostate Cancer Vaccines Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Prostate Cancer Vaccines Sales Volume (%), (2019-2030)
Figure 38. United States Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 44. China Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 46. China Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 56. India Prostate Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Prostate Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 58. India Prostate Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 59. Prostate Cancer Vaccines Industrial Chain
Figure 60. Prostate Cancer Vaccines Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
